Table 4. The correlation of clinicopathologic variables of ESCC with serum miRNA-146a in validation group.
Clinicopathological features | Low expression level (n=41) | High expression level (n=43) | Pa-value |
---|---|---|---|
Age (years) | 0.584 | ||
<65 | 21 | 22 | |
≥65 | 20 | 21 | |
Gender | 0.338 | ||
Male | 21 | 25 | |
Female | 20 | 18 | |
Smoking | 0.308 | ||
Never or light | 27 | 25 | |
Heavy | 14 | 18 | |
Drinking | 0.492 | ||
Never or light | 23 | 23 | |
Heavy | 18 | 20 | |
Differentiation | 0.785 | ||
Well | 13 | 11 | |
Moderate | 8 | 8 | |
Poor | 20 | 24 | |
T stage | 0.002 | ||
T1 | 7 | 24 | |
T2 | 18 | 8 | |
T3 | 10 | 8 | |
T4 | 6 | 3 | |
N stage | 0.303 | ||
N0 | 26 | 28 | |
N1 | 4 | 9 | |
N2 | 6 | 4 | |
N3 | 5 | 2 | |
TNM stage | 0.231 | ||
I | 7 | 14 | |
II | 19 | 18 | |
III | 15 | 11 |
Abbreviations: ESCC=oesophageal squamous cell cancer; miRNA-146a=microRNA-146a; Pa=χ2 test; TNM=tumour node metastasis.